Shear induced platelet procoagulant activity

剪切诱导的血小板促凝血活性

基本信息

  • 批准号:
    6584925
  • 负责人:
  • 金额:
    $ 21.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-03-15 至 2003-01-31
  • 项目状态:
    已结题

项目摘要

Upon activation, platelets from the primary hemostatic plug at sites of vascular injury. In addition, activated platelets provide an efficient pro- coagulant surface for the subsequent activation of the coagulation cascade. The transbilayer movement of anionic phospholipids from the inner to the outer leaflet of the platelet membrane is a major determinant of pro-coagulant activity. This is accompanied by the release of procoagulant membrane particles called microvesicles. Individuals with impaired generation of platelet procoagulant activity have a life-long bleeding diathesis (Scott syndrome) Our studies show that shear stress, such as that which occurs at a site of atherosclerotic narrowing of arteries, is a potent stimulus for the development of platelet procoagulant activity and microvesiculation. Moreover, thrombin accentuates the shear stress- induced anionic phospholipid exposure and microvesiculation. The microvesicles adhere to matrix components, provide a binding site for platelet adhesion, and localize to the site of vascular injury in vivo. Microvesicles bind beta2-glycoprotein I, an anionic phospholipid-binding plasma protein, which promotes its clearance by macrophages. The presence of autoantibodies to beta2-glycoprotein I, as well as inherited mutations in beta2-glycoprotein I (which impair its philosophical- binding) are associated with increased incidence of thrombosis. In this proposal, we will investigate the role of shear stress-induced platelet procoagulant activity on thrombus formation. The specific aims of this proposal are: (1) To define the signal transduction pathways leading to shear stress-induced platelet pro-coagulant activity. We will test the hypothesis that signal transduction that signal transduction through ITAM-containing proteins and Syk leads to anionic phospholipid exposure and microvesiculation. (2) To assess, under shear stress, the development of platelet pro-coagulant activity and its role in the stability of thrombus. The hypothesis to be tested: Platelets develop procoagulant activity following adhesion on von Willebrand factor and/or a collagen surface and this activity on adherent platelets plays a significant role in thrombus stability. (3) To define the role of beta2-glycoprotein I in the clearance of platelet-derived microvesicles from the circulation. The hypothesis to be tested: beta2-glycoprotein I binds to anionic phospholipid on the surface of platelet-derived microvesicles and mediates their clearance by macrophages. The corollary of this is that deficiency of beta2-glycoprotein I function will lead to a hypercoagulable state.
激活后,血小板从血管损伤部位的初级止血栓中流出。此外,活化的血小板为随后的凝血级联活化提供了有效的促凝血表面。阴离子磷脂从血小板膜的内小叶到外小叶的跨双层运动是促凝血活性的主要决定因素。这伴随着称为微泡的促凝血膜颗粒的释放。血小板促凝活性生成受损的个体具有终身出血素质(Scott综合征)。我们的研究表明,剪切应力,例如发生在动脉粥样硬化狭窄部位的剪切应力,是血小板促凝活性和微泡形成发展的有力刺激。此外,凝血酶加重剪切应力诱导的阴离子磷脂暴露和微泡形成。微泡粘附于基质组分,为血小板粘附提供结合位点,并定位于体内血管损伤部位。微泡结合β 2-糖蛋白I,一种阴离子磷脂结合血浆蛋白,可促进其被巨噬细胞清除。β 2-糖蛋白I自身抗体的存在,以及β 2-糖蛋白I的遗传突变(削弱其哲学结合)与血栓形成的发生率增加有关。在这个提议中,我们将研究剪切应力诱导的血小板促凝活性对血栓形成的作用。本研究的具体目的是:(1)明确切应力诱导血小板促凝活性的信号转导途径。我们将测试信号转导的假设,即通过含ITAM蛋白和Syk的信号转导导致阴离子磷脂暴露和微泡形成。(2)评估在剪切应力下血小板促凝活性的发展及其在血栓稳定性中的作用。待检验的假设:血小板在粘附于血管性血友病因子和/或胶原表面后产生促凝血活性,并且粘附血小板上的这种活性在血栓稳定性中起重要作用。(3)确定β 2-糖蛋白I在血小板衍生微泡从循环中清除中的作用。待检验的假设:β 2-糖蛋白I与血小板衍生的微泡表面上的阴离子磷脂结合,并介导它们被巨噬细胞清除。其必然结果是β 2-糖蛋白I功能的缺乏将导致高凝状态。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Perumal Thiagarajan其他文献

Perumal Thiagarajan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Perumal Thiagarajan', 18)}}的其他基金

CYTOSKELETON AND PLATELET CLEARANCE
细胞骨架和血小板清除率
  • 批准号:
    9752679
  • 财政年份:
    2018
  • 资助金额:
    $ 21.2万
  • 项目类别:
Platelet Microvesicles
血小板微泡
  • 批准号:
    8195600
  • 财政年份:
    2009
  • 资助金额:
    $ 21.2万
  • 项目类别:
Platelet Microvesicles
血小板微泡
  • 批准号:
    8542461
  • 财政年份:
    2009
  • 资助金额:
    $ 21.2万
  • 项目类别:
Platelet Microvesicles
血小板微泡
  • 批准号:
    7907799
  • 财政年份:
    2009
  • 资助金额:
    $ 21.2万
  • 项目类别:
Platelet Microvesicles
血小板微泡
  • 批准号:
    7791560
  • 财政年份:
    2009
  • 资助金额:
    $ 21.2万
  • 项目类别:
Platelet Microvesicles
血小板微泡
  • 批准号:
    8391536
  • 财政年份:
    2009
  • 资助金额:
    $ 21.2万
  • 项目类别:
Basic and Clinical Research Training in Thrombosis
血栓形成基础和临床研究培训
  • 批准号:
    7019108
  • 财政年份:
    2004
  • 资助金额:
    $ 21.2万
  • 项目类别:
Basic and Clinical Research Training in Thrombosis
血栓形成基础和临床研究培训
  • 批准号:
    7218610
  • 财政年份:
    2004
  • 资助金额:
    $ 21.2万
  • 项目类别:
Basic and Clinical Research Training in Thrombosis
血栓形成基础和临床研究培训
  • 批准号:
    7431613
  • 财政年份:
    2004
  • 资助金额:
    $ 21.2万
  • 项目类别:
ANTIBODIES WITH PROTHROMBINASE ACTIVITY IN LUPUS
狼疮中具有凝血酶原活性的抗体
  • 批准号:
    6650264
  • 财政年份:
    1999
  • 资助金额:
    $ 21.2万
  • 项目类别:

相似海外基金

Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
  • 批准号:
    10722686
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
病原体诱导的血液凝固中脂质过氧化和焦亡诱导的组织因子激活
  • 批准号:
    10571353
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
Elucidation of changes in electrical properties during the blood coagulation process and its use for measurement of blood coagulation status during extracorporeal circulation
阐明血液凝固过程中电特性的变化及其在体外循环期间血液凝固状态测量中的应用
  • 批准号:
    23K08266
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SBIR Phase II: Innovative Platform for Low Volume Blood Coagulation Analysis
SBIR II 期:低容量凝血分析的创新平台
  • 批准号:
    2134020
  • 财政年份:
    2022
  • 资助金额:
    $ 21.2万
  • 项目类别:
    Cooperative Agreement
Construction of a multilayered network to represent blood coagulation process
构建代表血液凝固过程的多层网络
  • 批准号:
    22K12252
  • 财政年份:
    2022
  • 资助金额:
    $ 21.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Protein S Regulates Blood Coagulation by Inhibiting Factor IXa
Protein S 通过抑制 IXa 因子调节凝血
  • 批准号:
    10616732
  • 财政年份:
    2022
  • 资助金额:
    $ 21.2万
  • 项目类别:
Development of thrombus prevention technology for ECMO devices based on the blood coagulation mechanism caused by viral infections
基于病毒感染凝血机制的ECMO装置血栓预防技术开发
  • 批准号:
    21K08817
  • 财政年份:
    2021
  • 资助金额:
    $ 21.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
  • 批准号:
    10452687
  • 财政年份:
    2021
  • 资助金额:
    $ 21.2万
  • 项目类别:
SBIR Phase II: CoagCare-A POC Blood Coagulation Diagnostic Platform That Utilizes A Hand-held Meter and Mechanically Sensitive Test Strips for Broad Spectrum Hemostasis Monitoring
SBIR II 期:CoagCare - POC 凝血诊断平台,利用手持式仪表和机械敏感试纸条进行广谱止血监测
  • 批准号:
    2050272
  • 财政年份:
    2021
  • 资助金额:
    $ 21.2万
  • 项目类别:
    Cooperative Agreement
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
  • 批准号:
    10283268
  • 财政年份:
    2021
  • 资助金额:
    $ 21.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了